Long-term efficacy and immunopersistence of an Escherichia coli-produced HPV-16/18 bivalent vaccine: an observational extension study following a randomised, double-blind Phase III clinical trial cohort.

Zhao F, Chen Q, Zhao C, Nie L, Hu S, Yin J, Qiu L, Bi Z, Quan J, Li Y, Li M, Zhang X, Pan Q, Li C, Ke L, Liu X, Zheng F, Dai C, Wang Z, Kuang X, Jia X, Su Y, Huang S, Zhang Q, Huang W, Wei L, Zhang J, Wu T, Qiao Y, Xia N

Open source

DOI: 10.1016/j.lanwpc.2025.101668
Published: 2025 Aug
Container: The Lancet regional health. Western Pacific
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.lanwpc.2025.101668,
  title = {Long-term efficacy and immunopersistence of an Escherichia coli-produced HPV-16/18 bivalent vaccine: an observational extension study following a randomised, double-blind Phase III clinical trial cohort.},
  author = {Zhao F and Chen Q and Zhao C and Nie L and Hu S and Yin J and Qiu L and Bi Z and Quan J and Li Y and Li M and Zhang X and Pan Q and Li C and Ke L and Liu X and Zheng F and Dai C and Wang Z and Kuang X and Jia X and Su Y and Huang S and Zhang Q and Huang W and Wei L and Zhang J and Wu T and Qiao Y and Xia N},
  year = {2025},
  journal = {The Lancet regional health. Western Pacific},
  doi = {10.1016/j.lanwpc.2025.101668},
  url = {https://doi.org/10.1016/j.lanwpc.2025.101668}
}

RIS

TY  - JOUR
TI  - Long-term efficacy and immunopersistence of an Escherichia coli-produced HPV-16/18 bivalent vaccine: an observational extension study following a randomised, double-blind Phase III clinical trial cohort.
AU  - Zhao F
AU  - Chen Q
AU  - Zhao C
AU  - Nie L
AU  - Hu S
AU  - Yin J
AU  - Qiu L
AU  - Bi Z
AU  - Quan J
AU  - Li Y
AU  - Li M
AU  - Zhang X
AU  - Pan Q
AU  - Li C
AU  - Ke L
AU  - Liu X
AU  - Zheng F
AU  - Dai C
AU  - Wang Z
AU  - Kuang X
AU  - Jia X
AU  - Su Y
AU  - Huang S
AU  - Zhang Q
AU  - Huang W
AU  - Wei L
AU  - Zhang J
AU  - Wu T
AU  - Qiao Y
AU  - Xia N
PY  - 2025
JO  - The Lancet regional health. Western Pacific
DO  - 10.1016/j.lanwpc.2025.101668
UR  - https://doi.org/10.1016/j.lanwpc.2025.101668
ER  -

APA

F, Z., Q, C., C, Z., L, N., S, H., J, Y., L, Q., Z, B., J, Q., Y, L., M, L., X, Z., Q, P., C, L., L, K., X, L., F, Z., C, D., Z, W., X, K., X, J., Y, S., S, H., Q, Z., W, H., L, W., J, Z., T, W., Y, Q., & N, X. (2025). Long-term efficacy and immunopersistence of an Escherichia coli-produced HPV-16/18 bivalent vaccine: an observational extension study following a randomised, double-blind Phase III clinical trial cohort.. The Lancet regional health. Western Pacific. https://doi.org/10.1016/j.lanwpc.2025.101668

Source records

pubmed · retrieved 2026-09-27T08:40:53.256Z